{
    "body": "Is c-met involved in the activation of the Akt pathway?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/17258200", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23345546", 
        "http://www.ncbi.nlm.nih.gov/pubmed/14570904", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18234991", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22820099", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23229794", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21687953", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17942284", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15522281", 
        "http://www.ncbi.nlm.nih.gov/pubmed/10714768", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19850646", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21536148", 
        "http://www.ncbi.nlm.nih.gov/pubmed/11821397", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18262389", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20233866", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22789825", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16278380", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17464994"
    ], 
    "ideal_answer": [
        "HGF-induced activation of c-Met is playing a pivotal role in the stimulation of c-Src activation, resulting in induction of phosphatidylinositol 3-kinase complexes p85\u03b1/p110\u03b1 and p85\u03b1/p110\u03b4, which is required for Akt-mediated activation of mammalian target of rapamycin, with consequent inhibition of I\u03baB kinase and nuclear factor-\u03baB activation, resulting in enhanced cell survival."
    ], 
    "exact_answer": "yes", 
    "concepts": [
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0043491", 
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0048012", 
        "http://www.uniprot.org/uniprot/SLTM_HUMAN", 
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D051057", 
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D019859", 
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0051896", 
        "http://www.uniprot.org/uniprot/AKT1_HUMAN"
    ], 
    "type": "yesno", 
    "id": "5318a955b166e2b806000020", 
    "snippets": [
        {
            "offsetInBeginSection": 421, 
            "offsetInEndSection": 726, 
            "text": "Amplification of MET has been reported in approximately 5%-22% of lung tumors with acquired resistance to small-molecule inhibitors of the epidermal growth factor receptor (EGFR). Resistance to EGFR inhibitors is likely mediated through downstream activation of the phosphoinositide 3-kinase /AKT pathway.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23345546", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 727, 
            "offsetInEndSection": 965, 
            "text": "Simultaneous treatment of resistant tumors with a MET inhibitor plus an EGFR inhibitor can abrogate activation of downstream effectors of cell growth, proliferation, and survival, thereby overcoming acquired resistance to EGFR inhibitors.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23345546", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 839, 
            "offsetInEndSection": 885, 
            "text": "HGF mediated both ERK and Akt phosphorylation.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23229794", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1263, 
            "offsetInEndSection": 1360, 
            "text": "ERK/Akt signaling, but not the Smad pathway, may be one of the main processes in HGF-induced EMT,", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23229794", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1442, 
            "offsetInEndSection": 1503, 
            "text": "The MAPK/Akt pathway is indispensable in HGF/c-Met signaling.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23229794", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 115, 
            "text": "Inhibition of c-Met activation sensitizes osteosarcoma cells to cisplatin via suppression of the PI3K-Akt signaling", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22820099", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 933, 
            "offsetInEndSection": 1083, 
            "text": "Specifically, we demonstrated that inhibition of c-Met activity led to suppression of the PI3K-Akt pathway, thus enhancing cisplatin chemosensitivity.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22820099", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1084, 
            "offsetInEndSection": 1245, 
            "text": "Our study clearly suggests that inhibition of c-Met activity can effectively sensitize osteosarcoma cells to cisplatin via suppression of the PI3K-Akt signaling.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22820099", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 604, 
            "offsetInEndSection": 806, 
            "text": "We found that a dual Met/VEGF receptor 2 kinase inhibitor, E7050, circumvented HGF-induced EGFR-TKI resistance in EGFR mutant lung cancer cell lines by inhibiting the Met/Gab1/PI3K/Akt pathway in vitro.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22789825", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 514, 
            "offsetInEndSection": 728, 
            "text": "Here, we report that i) treatment of RL95-2 cells with HGF resulted in phosphorylation of the HGF receptor c-Met, activation of Akt and I\u03baB, translocation of NF-\u03baB into the nucleus, and up-regulation of COX-2 mRNA;", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21687953", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1062, 
            "offsetInEndSection": 1205, 
            "text": "Our data suggest that HGF possesses chemotactic ability, has anti-apoptosis action, and induces cellular infiltration via the PI3K/Akt pathway;", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21687953", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 177, 
            "text": "Hepatocyte growth factor-induced c-Src-phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway inhibits dendritic cell activation by blocking I\u03baB kinase activity", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21536148", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 715, 
            "offsetInEndSection": 938, 
            "text": "Activation of c-Src in turn establishes a complex consisting of phosphatidylinositol 3-kinase and c-MET, and promotes downstream activation of the phosphatidylinositol 3-kinase/AKT pathway and mammalian target of rapamycin.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21536148", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1150, 
            "offsetInEndSection": 1443, 
            "text": "Notably, hepatocyte growth factor-stimulated c-Src activation results in induction of phosphatidylinositol 3-kinase complexes p85\u03b1/p110\u03b1 and p85\u03b1/p110\u03b4, which is required for activation of mammalian target of rapamycin, and consequent inhibition of I\u03baB kinase and nuclear factor-\u03baB activation.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21536148", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1444, 
            "offsetInEndSection": 1735, 
            "text": "Our findings, for the first time, have identified the c-Src-phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway that plays a pivotal role in mediating the inhibitory effects of hepatocyte growth factor on dendritic cell activation by blocking nuclear factor-\u03baB signaling.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21536148", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1280, 
            "offsetInEndSection": 1487, 
            "text": "Cyr61 siRNA inhibited a second phase of Akt phosphorylation measured 12 hours after cell stimulation with HGF and also inhibited HGF-induced phosphorylation of the Akt target glycogen synthase kinase 3alpha.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20233866", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1342, 
            "offsetInEndSection": 1594, 
            "text": "HGF+EGF treatment increased the duration of ERK1/2 and AKT activation compared to HGF or EGF alone. All these data indicate that a crosstalk between the EGF and HGF pathways in mammary epithelial cells may modulate the development of the mammary gland.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19850646", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 125, 
            "text": "Hepatocyte growth factor and c-Met promote dendritic maturation during hippocampal neuron differentiation via the Akt pathway", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18262389", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 758, 
            "offsetInEndSection": 1053, 
            "text": "Consistent with these results, HGF activated Akt, which phosphorylates glycogen synthase kinase-3beta (GSK-3beta) to inactivate it, and reduced phosphorylation of microtubule-associated protein 2 (MAP2), which can promote microtubule polymerization and dendrite elongation when dephosphorylated.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18262389", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1054, 
            "offsetInEndSection": 1374, 
            "text": "Conversely, pharmacological inhibition of c-Met with its specific inhibitor, PHA-665752, or genetic knock-down of c-Met with short hairpin RNAs (shRNAs) suppressed HGF-induced phosphorylation of Akt and GSK-3beta, increased phosphorylation of MAP2, and reduced dendrite number and length in cultured hippocampal neurons.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18262389", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1458, 
            "offsetInEndSection": 1699, 
            "text": "Inhibiting Akt activity with the phosphoinositide-3-kinase inhibitor LY294002 or Akt inhibitor X suppressed HGF-induced phosphorylation of GSK-3beta, increased MAP2 phosphorylation, and blocked the ability of HGF to enhance dendritic length.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18262389", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1700, 
            "offsetInEndSection": 1844, 
            "text": "These observations indicate that HGF and c-Met can regulate the early stages of dendrite maturation via activation of the Akt/GSK-3beta pathway.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18262389", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 111, 
            "text": "Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18234991", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 1031, 
            "offsetInEndSection": 1415, 
            "text": "HGF was found to enhance cell migration, and that HGF-induced migration depends on PI3K/Akt pathway. The activation of PI3K/Akt pathway induced by the HGF/c-Met axis is involved in the downregulation of cell adhesion molecules E-cadherin and beta-catenin, contributing to the attenuation of cell-cell adhesion and promoting the enhanced motility and migration of uveal melanoma cells.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18234991", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 122, 
            "text": "HGF protects cultured cortical neurons against hypoxia/reoxygenation induced cell injury via ERK1/2 and PI-3K/Akt pathways", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17942284", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 462, 
            "offsetInEndSection": 528, 
            "text": "HGF stimulated both ERK1/2 and Akt activities in cortical neurons.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17942284", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 529, 
            "offsetInEndSection": 718, 
            "text": "Inhibition of ERK activation completely abolished the protective effects of HGF, and inhibition of Akt activation reduced, but did not completely eliminate the HGF mediated neuroprotection.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17942284", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 719, 
            "offsetInEndSection": 837, 
            "text": "It is suggested that the neuroprotection of HGF depend on ERK1/2 pathway, and, to a lesser extent, PI-3K/Akt pathway. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17942284", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 107, 
            "text": "Met signals hepatocyte survival by preventing Fas-triggered FLIP degradation in a PI3k-Akt-dependent manner", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17464994", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 1318, 
            "offsetInEndSection": 1488, 
            "text": "Thus, Met acting on PI3K and Akt ensures high levels of FLIPL, and disruption of this pathway contributes to hepatic apoptosis and possibly to Fas-related liver diseases.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17464994", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 744, 
            "offsetInEndSection": 990, 
            "text": "The HGF-induced increase in Nkx 2.5 expression was inhibited by co-treatment with the PI3 kinase inhibitors Wortmannin and LY294002, but not by its inactive homolog LY303511, suggesting an involvement of the PI3 kinase/Akt pathway in this effect.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17258200", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 150, 
            "text": "X-Linked inhibitor of apoptosis protein expression level in colorectal cancer is regulated by hepatocyte growth factor/C-met pathway via Akt signaling", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16278380", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 1263, 
            "offsetInEndSection": 1347, 
            "text": "Activation of XIAP expression by HGF was inhibited by siRNA targeting Akt1 and Akt2.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16278380", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1361, 
            "offsetInEndSection": 1419, 
            "text": "Activation of C-MET enhances XIAP through the Akt pathway.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16278380", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 113, 
            "text": "Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15522281", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 1167, 
            "offsetInEndSection": 1331, 
            "text": "A significant reduction in apoptosis in the HGF-treated hearts was observed compared with control hearts, and was strongly associated with increased Akt activation.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15522281", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1461, 
            "offsetInEndSection": 1546, 
            "text": "The antiapoptotic effect of HGF was mediated by activation of PI3-kinase/Akt pathway.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15522281", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 508, 
            "offsetInEndSection": 874, 
            "text": "The protective effect of HGF/SF against the ADR-induced apoptosis was abolished in the presence of either LY294002, an inhibitor of phosphatidylinositol-3'-OH kinase (PI3-K) or 1L-6-hydroxymethyl-chiro-inositol 2-(R)-2-O-methyl-3-O-octadecylcarbonate, an inhibitor of Akt, thus implicating the activation of PI3-K-Akt signaling in the antiapoptotic action of HGF/SF.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/14570904", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 875, 
            "offsetInEndSection": 985, 
            "text": "Immunoblotting analysis revealed that HGF/SF stimulated the sustained phosphorylation of Akt for several hours", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/14570904", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1048, 
            "offsetInEndSection": 1185, 
            "text": "Furthermore, ADR-induced activation of caspase-9, a downstream molecule of Akt, was inhibited for at least 24 h after HGF/SF stimulation,", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/14570904", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1479, 
            "offsetInEndSection": 1656, 
            "text": "These results indicate that HGF/SF, but not EGF, transmitted protective signals against ADR-induced apoptosis by causing sustained activation of the PI3-K-Akt signaling pathway.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/14570904", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 186, 
            "text": "Hepatocyte growth factor/scatter factor inhibits UVB-induced apoptosis of human keratinocytes but not of keratinocyte-derived cell lines via the phosphatidylinositol 3-kinase/AKT pathway", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/11821397", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 349, 
            "offsetInEndSection": 575, 
            "text": "When we analyzed the signaling pathways initiated by the HGF/SF receptor c-met, we found that the phosphatidylinositol (PI) 3-kinase and its downstream-element AKT and the mitogen-activated protein (MAP) kinase were activated.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/11821397", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 576, 
            "offsetInEndSection": 728, 
            "text": "Inhibition of PI 3-kinase led to a complete abrogation of the anti-apoptotic effect of HGF/SF, whereas blockade of the MAP kinase pathway had no effect.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/11821397", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1261, 
            "offsetInEndSection": 1411, 
            "text": "We now show in detached cells a cooperative effect of HGF and FN in the activation of PI 3-kinase and on the phosphorylation of PKB/Akt at serine 473.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10714768", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1412, 
            "offsetInEndSection": 1554, 
            "text": "PI 3-kinase activity is also required for the HGF- and fibronectin-induced survival responses, as well as anchorage-independent colony growth.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10714768", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1645, 
            "offsetInEndSection": 1964, 
            "text": "Together, these results demonstrate that the PI 3-kinase/Akt pathway is a key effector of the HGF- and fibronectin-induced survival response of breast carcinoma cells under detached conditions and corroborate an interaction between integrin and HGF/ Met signalling pathways in the development of invasive breast cancer.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10714768", 
            "endSection": "abstract"
        }
    ]
}